Constanza Maximiano Alonso

Dr. Constanza Maximiano Alonso

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2021 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
AÁAlejandro Álvarez-Bustos
Alejandro Álvarez-Bustos
CPCristina G. de Pedro
Cristina G. de Pedro
MRMaría Romero-Elías
María Romero-Elías
JRJavier Ramos
Javier Ramos
POPablo Osorio
Pablo Osorio
ARAna Ruiz-Casado
Ana Ruiz-Casado

24 January 2020 in Clinical and Translational Oncology
Verified
Journal Article
Open access
PDF file
AJA. de Juan
A. de Juan
ARAndres Redondo
Andres Redondo
MRMaria Jesus Rubio
Maria Jesus Rubio
YGY. García
Y. García
JCJ. Cueva
J. Cueva
AOA. Oaknin
A. Oaknin
Cervical cancer (CC) is the fourth most common cancer in women worldwide, strongly linked to high-risk human papilloma virus infection. In high-income countries, the screening programs have dramatically decreased the incidence of CC; however, the lack of accessibility to them in developing countries makes CC an important cause of mortality. Clinical stage is the most relevant prognostic factor in CC. The new FIGO staging system published in 2018 is more accurate than the previous one since it takes into account the lymph node status. In early stages, the primary treatment is surgery—with some concerns recently raised regarding minimally invasive surgery because it might decrease survival—or radiotherapy, whereas concomitant chemo-radiotherapy is the conventional approach in locally advanced stages. For recurrent or metastatic CC, the combination of chemotherapy plus bevacizumab is the preferred therapy. Immunotherapy approach based on checkpoint inhibitors is evolving as the election therapy following failure to platinum therapy.

2 November 2023 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
PDF file
AOAylen Vanessa Ospina-Serrano
Aylen Vanessa Ospina-Serrano
CAConstanza Maximiano Alonso
Constanza Maximiano Alonso
BCBlanca Cantos
Blanca Cantos
MTMaria Torrente
Maria Torrente
MMMéndez Méndez
Méndez Méndez
Mariano ProvencioMariano Provencio
Mariano Provencio


21 December 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MRMaría Romero-Elías
María Romero-Elías
AÁAlejandro Álvarez-Bustos
Alejandro Álvarez-Bustos
BCBlanca Cantos
Blanca Cantos
CAConstanza Maximiano Alonso
Constanza Maximiano Alonso
MMMéndez Méndez
Méndez Méndez
ARAna Ruiz-Casado
Ana Ruiz-Casado
Background: Physical fitness (PF) is an expression of the physiological functioning of multiple body components. PF is an important prognostic factor in terms of cardiovascular mortality, cancer mortality, and all-cause mortality. PF has been related to some biomarkers in the general population but not in breast cancer survivors (BCS). Purpose: To evaluate the effects of PF on biomarkers potentially related to physical activity (PA) in a sample of BCS. Methods: Cross-sectional study. A total of 84 BCS (mean age 54) who had finished their treatment were recruited. Different components of PF were evaluated, namely body composition (anthropometry), cardiorespiratory fitness (one-mile walk test), muscular (handgrip and sit-to-stand timed test), and motor (gait speed) components. Sexual hormones, inflammation, and insulin resistance biomarkers were measured. Results: C-Reactive Protein (CRP) was associated with every component of physical fitness: cardiorespiratory fitness (p-value = 0.002), muscular (sit-to-stand timed test, p-value = 0.002) and motor (gait speed, p-value = 0.004) components, and body composition (body mass index, p-value = 0.003; waist, p-value < 0.000; and waist-to-hip index, p-value = 0.012). CRP also was associated with “poor physical condition,” a constructed variable that encompasses all components of physical fitness (p-value < 0.001). Insulin was associated with cardiorespiratory fitness and gait speed (p-values = 0.002 and 0.024, respectively). Insulin-like Growth Factor-1 was negatively associated with waist perimeter and waist-to-hip ratio. Conclusions: CRP can also be considered an indicator of poor PF in BCS. Implications for cancer survivors: in case of elevation of CRP indicating cardiovascular risk, health professionals should recommend lifestyle changes to improve BCS physical condition.

27 October 2010 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
PDF file
CAConstanza Maximiano Alonso
Constanza Maximiano Alonso
ARAntonio Carlos Sánchez Ruiz
Antonio Carlos Sánchez Ruiz
BIBlanca Cantos Sánchez de Ibargüen
Blanca Cantos Sánchez de Ibargüen
MGMiriam Méndez García
Miriam Méndez García
IRIsabel S. Ronco
Isabel S. Ronco
Mariano ProvencioMariano Provencio
Mariano Provencio